Every day, the people of Memorial Sloan Kettering Cancer Center (MSK) are driven by a singular mission: ending cancer for life. That relentless focus enables us to provide the world’s best, most ...

Memorial Sloan Kettering Cancer Center is proud to announce the formation of MSK Ventures, a dedicated venture capital fund launching in 2026. MSK Ventures is designed to invest in high-conviction ...

At The Society of MSK's Spring Ball, the chic uptown crowd showed up for an unforgettable night of glamour and philanthropy.

Sidekick Health, a digital health innovation company, today announced the launch of its musculoskeletal (MSK) health program ...

AI, comedy, and community unite at MSK’s Spring Ball to drive cancer breakthroughs, raising millions while turning data, ...

Nothing feels more enchanting in November than entering the golden-hued Grand Ballroom of the Plaza Hotel for The Society of Memorial Sloan Kettering’s annual Fall Party. For the second year in a row ...

Juniper Biosciences today announced a strategic licensing agreement with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the development of JBS-003 (18F-fluoromisonidazole, or FMISO). This ...

DarioHealth announced today that it is expanding its digital chronic-disease-management business beyond diabetes and hypertension with the purchase of Upright Technologies, a musculoskeletal (MSK) ...

The Society of Memorial Sloan-Kettering (MSK) held its 16th Annual Spring Ball on Thursday night, in the freshly redone ballroom of the Pierre Hotel, where 430 guests came out to support this ...

Musculoskeletal (MSK) is routinely one of the three most expensive categories of care (along with cardio-metabolic disease and cancer care). Dr. Steve Schutzer, an orthopedic surgeon for 34 years, is ...